Page 1

X UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , DC 20549 FORM 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Delaware ( State or other jurisdiction of incorporation or organization ) 3451 Plano Parkway , Lewisville , Texas ( Address of principal executive offices ) Common Stock , $ 0.10 par value ( Title of Class ) Large accelerated filer Non - accelerated filer Commission File Number : 0-19961 ORTHOFIX® ORTHOFIX MEDICAL INC . ( Exact name of registrant as specified in its charter ) ( 214 ) 937-2000 ( Registrant's telephone number , including area code ) Securities registered pursuant to Section 12 ( b ) of the Act : OFIX ( Trading Symbol ) Securities registered pursuant to Section 12 ( g ) of the Act : None Indicate by check mark if the registrant is a well - known seasoned issuer , as defined in Rule 405 of the Securities Act . Yes Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . Yes Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . Yes No No | Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( §232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . Yes > No X 98-1340767 ( I.R.S. Employer Identification No. ) 75056 ( Zip Code ) Accelerated filer Smaller reporting company Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , a smaller reporting company , or emerging growth company . See the definitions of " large accelerated filer , " " accelerated filer , ” “ smaller reporting company , ” and “ emerging growth company " in Rule 12b - 2 of the Exchange Act . Nasdaq Global Select Market ( Name of Exchange on Which Registered ) No Emerging Growth Company If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . 0 Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. §7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined in Rule 12b - 2 of the Act ) . Yes No | The aggregate market value of registrant's common stock held by non - affiliates , based upon the closing price of the common stock on the last business day of the fiscal quarter ended June 30 , 2020 , as reported by the Nasdaq Global Select Market , was approximately $ 614.7 million . As of February 22 , 2021 , 19,512,109 shares of common stock were issued and outstanding . DOCUMENTS INCORPORATED BY REFERENCE Certain sections of the registrant's definitive proxy statement to be filed with the Commission in connection with the Orthofix Medical Inc. 2021 Annual General Meeting of Shareholders are incorporated by reference in Part III of this Annual Report .